Show me any mammal studies that show more is worse!
Of all of the “gurus” out there, you must pick one to follow for the dose, frequency, and delivery that you think is best for you. I choose to follow one of the pioneers.
Mikhail (Misha) V. Blagosklonny graduated with an MD and PhD from First Pavlov State Medical University of St. Petersburg, Russia. Dr. Mikhail V. Blagosklonny subsequently relocated to the United States, where he was awarded the prestigious Fogarty Fellowship from the National Institutes of Health. During his fellowship in Leonard Neckers’ laboratory at the National Cancer Institute (NCI), he was a co-author of 18 publications on diverse biomedical topics, including targeting HSP90, p53, Bcl2, Erb2, and Raf-1. He also was the last author on a clinical phase I/II trial paper.
Professor of Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York
The higher the dose, the longer lifespan.
“in humans therefore the highest acceptable dose that does not yet cause unacceptable side effects may be optimal for longevity”
Dr. Blagosklonny was taking rapamycin before he discovered he had cancer. of course he was smoking at the same time he was taking rapamycin.
My present dose is 5 mg with GFJ juice weekly. Some consider this a high dose but I don’t because it causes me no adverse side effects. After a while he came to the guess that maybe once a week dosing is best. When I first started with rapamycin, I was taking 20 mgs with GFJ. Other than diarrhea, I experienced no serious side effects, but I did lose all of my arthritic pain among other things.
At 5mg with GFJ weekly and a few drugs, metformin, bempedoic acid, etc. all markers that I have measured are excellent.
Interview with Mikhail Blagosklonny.